Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 784 | 764 | 25,717 | 703 | 1,611 |
| Gross Profit | 784 | 764 | 25,717 | 703 | 1,611 |
| Operating Expenses | 11,498 | 7,398 | 6,867 | 5,597 | 9,307 |
| Operating Income | -10,714 | -6,634 | 18,850 | -4,894 | -7,696 |
| Interest Expense | 315 | 333 | 467 | 451 | 564 |
| Other Income | 2,648 | 2,506 | -1,954 | 2,210 | 8,815 |
| Pre-tax Income | -8,381 | -4,461 | 16,429 | -3,135 | 555 |
| Net Income Continuous | -8,381 | -4,461 | 16,429 | -3,135 | 555 |
| Net Income | $-8,381 | $-4,461 | $16,429 | $-3,135 | $555 |
| EPS Basic Total Ops | -0.52 | -0.25 | 1.02 | -0.20 | 0.04 |
| EPS Basic Continuous Ops | -0.52 | -0.25 | 1.02 | -0.20 | 0.04 |
| EPS Diluted Total Ops | -0.52 | 0.41 | 1.02 | -0.20 | -0.62 |
| EPS Diluted Continuous Ops | -0.52 | -0.26 | 1.02 | -0.20 | 0.04 |
| EBITDA(a) | $-10,765 | $-6,677 | $18,850 | $-4,894 | $-7,696 |